1. Market Research
  2. > Therapy Industry

Monoclonal Antibody Industry, April 2017 Market Reports from Top Publishers

You might be interested in: Infectious Disease, Diagnostics, In Vitro Diagnostic Reagent, Molecular Diagnostic, Hepatitis, Sexually Transmitted Disease, Anti-Infective, Coagulation Diagnostic, Therapy, Biosimilar, Hormone, HIV AIDS, Cancer, Hematology Instrument, Biopharmaceutical, Pap Smear, Breast Cancer, Protein, Asthma, Chemotherapy.


 
1-10 of 58 reports for Monoclonal Antibody

Purchase Reports From Reputable Market Research Publishers

The 2018-2023 World Outlook for Rheumatoid Arthritis (RA) Monoclonal Antibodies (mAb)

The 2018-2023 World Outlook for Rheumatoid Arthritis (RA) Monoclonal Antibodies (mAb)

  • $ 995
  • Industry report
  • April 2017
  • by ICON Group

This study covers the world outlook for rheumatoid arthritis (RA) monoclonal antibodies (mAb) across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential ...

The 2018-2023 World Outlook for Therapeutic Monoclonal Antibodies

The 2018-2023 World Outlook for Therapeutic Monoclonal Antibodies

  • $ 995
  • Industry report
  • April 2017
  • by ICON Group

This study covers the world outlook for therapeutic monoclonal antibodies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings ...

The 2018-2023 World Outlook for Gastric Cancer Monoclonal Antibodies (mAb)

The 2018-2023 World Outlook for Gastric Cancer Monoclonal Antibodies (mAb)

  • $ 995
  • Industry report
  • April 2017
  • by ICON Group

This study covers the world outlook for gastric cancer monoclonal antibodies (mAb) across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry ...

The 2018-2023 World Outlook for Colorectal Cancer Monoclonal Antibodies (mAb)

The 2018-2023 World Outlook for Colorectal Cancer Monoclonal Antibodies (mAb)

  • $ 995
  • Industry report
  • April 2017
  • by ICON Group

This study covers the world outlook for colorectal cancer monoclonal antibodies (mAb) across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry ...

The 2018-2023 World Outlook for AntiCD20 Monoclonal Antibodies

The 2018-2023 World Outlook for AntiCD20 Monoclonal Antibodies

  • $ 995
  • Industry report
  • April 2017
  • by ICON Group

This study covers the world outlook for AntiCD20 Monoclonal antibodies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings ...

The 2018-2023 World Outlook for Esophageal Cancer Monoclonal Antibodies (mAb)

The 2018-2023 World Outlook for Esophageal Cancer Monoclonal Antibodies (mAb)

  • $ 995
  • Industry report
  • April 2017
  • by ICON Group

This study covers the world outlook for esophageal cancer monoclonal antibodies (mAb) across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry ...

The 2018-2023 World Outlook for Monoclonal Antibody (MAb)-based Products

The 2018-2023 World Outlook for Monoclonal Antibody (MAb)-based Products

  • $ 995
  • Industry report
  • April 2017
  • by ICON Group

This study covers the world outlook for Monoclonal Antibody (MAb)-based products across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry ...

The 2018-2023 World Outlook for Monoclonal Antibodies

The 2018-2023 World Outlook for Monoclonal Antibodies

  • $ 995
  • Industry report
  • April 2017
  • by ICON Group

This study covers the world outlook for monoclonal antibodies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), ...

The 2018-2023 World Outlook for Breast Cancer Monoclonal Antibodies (mAb)

The 2018-2023 World Outlook for Breast Cancer Monoclonal Antibodies (mAb)

  • $ 995
  • Industry report
  • April 2017
  • by ICON Group

This study covers the world outlook for breast cancer monoclonal antibodies (mAb) across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry ...

The 2018-2023 World Outlook for Biosimilar Monoclonal Antibodies (mAb)

The 2018-2023 World Outlook for Biosimilar Monoclonal Antibodies (mAb)

  • $ 995
  • Industry report
  • April 2017
  • by ICON Group

This study covers the world outlook for biosimilar monoclonal antibodies (mAb) across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings ...

About 5300 reports for Monoclonal Antibody

Download Unlimited Documents from Trusted Public Sources

Monoclonal Antibody Market in the US and Europe

  • February 2015
    6 pages
  • Monoclonal Anti...  

  • United States  

    Europe  

View report >

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.